BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23313147)

  • 1. FcRγ promotes T cell apoptosis in Fas-deficient mice.
    Juvet SC; Thomson CW; Kim EY; Joe B; Adeyi O; Zhang L
    J Autoimmun; 2013 May; 42():80-93. PubMed ID: 23313147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FcRγ controls the fas-dependent regulatory function of lymphoproliferative double negative T cells.
    Juvet SC; Thomson CW; Kim EY; Han M; Zhang L
    PLoS One; 2013; 8(6):e65253. PubMed ID: 23762329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A; Wada T; Kinoshita K; Tesch G; Kelley VR
    J Immunol; 1998 Jul; 161(1):494-503. PubMed ID: 9647261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
    Benihoud K; Bonardelle D; Bobé P; Kiger N
    Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of receptor for advanced glycation end products exacerbates lymphoproliferative syndrome and lupus nephritis in B6-MRL Fas lpr/j mice.
    Goury A; Meghraoui-Kheddar A; Belmokhtar K; Vuiblet V; Ortillon J; Jaisson S; Devy J; Le Naour R; Tabary T; Cohen JH; Schmidt AM; Rieu P; Touré F
    J Immunol; 2015 Apr; 194(8):3612-22. PubMed ID: 25762779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha.
    Rifkin IR; Channavajhala PL; Kiefer HL; Carmack AJ; Landesman-Bollag E; Beaudette BC; Jersky B; Salant DJ; Ju ST; Marshak-Rothstein A; Seldin DC
    J Immunol; 1998 Nov; 161(10):5164-70. PubMed ID: 9820486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired peripheral deletion of activated T cells in mice lacking the common cytokine receptor gamma-chain: defective Fas ligand expression in gamma-chain-deficient mice.
    Nakajima H; Leonard WJ
    J Immunol; 1997 Nov; 159(10):4737-44. PubMed ID: 9366397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic expression of Fas in T cells blocks lymphoproliferation but not autoimmune disease in MRL-lpr mice.
    Fukuyama H; Adachi M; Suematsu S; Miwa K; Suda T; Yoshida N; Nagata S
    J Immunol; 1998 Apr; 160(8):3805-11. PubMed ID: 9558084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse.
    Zhou T; Bluethmann H; Eldridge J; Berry K; Mountz JD
    J Immunol; 1993 Apr; 150(8 Pt 1):3651-67. PubMed ID: 7682246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
    Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
    Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased CD4-CD8- TCR-alpha beta + cells in lpr/lpr mice lacking beta 2-microglobulin.
    Mixter PF; Russell JQ; Durie FH; Budd RC
    J Immunol; 1995 Mar; 154(5):2063-74. PubMed ID: 7868883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-12 drives IFN-gamma-dependent autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A; Tesch G; Kinoshita K; Maron R; Weiner HL; Kelley VR
    J Immunol; 1999 Dec; 163(12):6884-91. PubMed ID: 10586090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional roles of Fas and Bcl-2-regulated apoptosis of T lymphocytes.
    Van Parijs L; Biuckians A; Abbas AK
    J Immunol; 1998 Mar; 160(5):2065-71. PubMed ID: 9498742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extinction of IL-12 signaling promotes Fas-mediated apoptosis of antigen-specific T cells.
    Marth T; Zeitz M; Ludviksson BR; Strober W; Kelsall BL
    J Immunol; 1999 Jun; 162(12):7233-40. PubMed ID: 10358170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The proliferative in vivo activities of lpr double-negative T cells and the primary role of p59fyn in their activation and expansion.
    Balomenos D; Rumold R; Theofilopoulos AN
    J Immunol; 1997 Sep; 159(5):2265-73. PubMed ID: 9278315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional expression of Fas (CD95) protein in autoimmune lpr mice.
    Cui H; Ju ST; Sherr DH
    Cell Immunol; 1996 Nov; 174(1):35-41. PubMed ID: 8929452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.
    Yajima K; Nakamura A; Sugahara A; Takai T
    Eur J Immunol; 2003 Apr; 33(4):1020-9. PubMed ID: 12672068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas/Fas ligand signaling during gestational T cell development.
    Fleck M; Zhou T; Tatsuta T; Yang P; Wang Z; Mountz JD
    J Immunol; 1998 Apr; 160(8):3766-75. PubMed ID: 9558079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Src-homology domain 2-bearing protein tyrosine phosphatase-1 inhibits antigen receptor-induced apoptosis of activated peripheral T cells.
    Zhang J; Somani AK; Watt S; Mills GB; Siminovitch KA
    J Immunol; 1999 Jun; 162(11):6359-67. PubMed ID: 10352248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil apoptosis in autoimmune Fas-defective MRL lpr/lpr mice.
    Giudice ED; Ciaramella A; Balestro N; Neumann D; Romano PG; Cesaroni MP; Maurizi G; Ruggiero P; Boraschi D; Bossù P
    Eur Cytokine Netw; 2001; 12(3):510-7. PubMed ID: 11566632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.